Phage therapy: Beyond antibacterial action

Frontiers in Medicine

Volumn 5, Issue MAY, 2018, Pages

  Górski, Andrzej ^a,b   Jończyk Matysiak, Ewa ^a   Miedzybrodzki, Ryszard ^a,b   Weber Dabrowska, Beata ^a   Łusiak Szelachowska, Marzanna ^a   Bagińska, Natalia ^a   Borysowski, Jan ^b   Łobocka, Malgorzata B ^c,d   Wegrzyn, Alicja ^c   Wȩgrzyn, Grzegorz ^e  

^a INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

^c INSTITUTE OF BIOCHEMISTRY AND BIOPHYSICS   (Poland)

^d WARSAW UNIVERSITY OF LIFE SCIENCES   (Poland)

^e UNIVERSITY OF GDA SK   (Poland)

Author keywords

Immunomodulation; Inflammation; Phage; Phage therapy; Prophage induction

Indexed keywords

EID: 85047864601     PISSN: None     EISSN: 2296858X     Source Type: Journal    
DOI: 10.3389/fmed.2018.00146     Document Type: Article

References (101)

1. O'Neill J. Tackling Drug-Resistant Infections Globally: Final Report and Recommendations. The Review on Antimicrobial Resistance (2016)
2. Watts G. Phage therapy: revival of the bygone antimicrobial. Lancet (2017) 390:2539-40. doi: 10.1016/S0140-6736(17)33249-X
3. Lyon J. Phage therapy's role in combating antibiotic-resistant pathogens. JAMA (2017) 318:1746-8. doi: 10.1001/jama.2017.12938
4. Guglielmi G. Do bacteriophage guests protect human health? Science (2017) 358:982-3. doi: 10.1126/science.358.6366.982
5. Jennes S, Merabishvili M, Soentjens P, Pang KW, Rose T, Keersebilck E, et al. Use of bacteriophages in the treatment of colistin-only-sensitive Pseudomonas aeruginosa septicaemia in a patient with acute kidney injury-a case report. Crit Care (2017) 21:129. doi: 10.1186/s13054-017-1709-y
6. Duplessis C, Biswas B, Hanisch B, Perkins M, Henry M, Quinones J, et al. Refractory Pseudomonas bacteremia in a 2-year-old sterilized by bacteriophage therapy. J Pediatric Infect Dis Soc. (2017). doi: 10.1093/jpids/pix056. [Epub ahead of print]
7. Schooley RT, Biswas B, Gill JJ, Hernandez-Morales A, Lancaster J, Lessor L, et al. Development and use of personalized bacteriophage-based therapeutic cocktails to treat a patient with a disseminated resistant Acinetobacter baumannii infection. Antimicrob Agents Chemother. (2017) 61:e00954-17. doi: 10.1128/AAC.00954-17
8. Górski A, Miedzybrodzki R, Weber-Dabrowska B, Fortuna W, Letkiewicz S, Rogóz P, et al. Phage therapy: combating infections with potential for evolving from merely a treatment for complications to targeting diseases. Front Microbiol. (2016) 7:1515. doi: 10.3389/fmicb.2016.01515
9. Górski A, Dabrowska K, Miedzybrodzki R, Weber-Dabrowska B, Lusiak-Szelachowska M, Jonczyk-Matysiak E, et al. Phages and immunomodulation. Fut Microbiol. (2017) 12:905-14. doi: 10.2217/fmb-2017-0049
10. Malki K, Sible E, Cooper A, Garretto A, Bruder K, Watkins SC, et al. Seven bacteriophages isolated from the female urinary microbiota. Genome Announc. (2016) 4:e01003-16. doi: 10.1128/genomeA.01003-16
11. Brown-Jaque M, Muniesa M, Navarro F. Bacteriophages in clinical samples can interfere with microbiological diagnostic tools. Sci Rep. (2016) 6:33000. doi: 10.1038/srep33000
12. De Vlaminck I, Khush KK, Strehl C, Kohli B, Luikart H, Neff NF, et al. Temporal response of the human virome to immunosuppression and antiviral therapy. Cell (2013) 155:1178-87. doi: 10.1016/j.cell.2013.10.034
13. Kowarsky M, Camunas-Soler J, Kertesz M, De Vlaminck I, Koh W, Pan W, et al. Numerous uncharacterized and highly divergent microbes which colonize humans are revealed by circulating cell-free DNA. Proc Natl Acad Sci USA (2017) 114:9623-8. doi: 10.1073/pnas.1707009114
14. Thannesberger J, Hellinger HJ, Klymiuk I, Kastner MT, Rieder FJJ, Schneider M, et al. Viruses comprise an extensive pool of mobile genetic elements in eukaryote cell cultures and human clinical samples. FASEB J. (2017) 31:1987-2000. doi: 10.1096/fj.201601168R
15. Górski A, Wazna E, Dabrowska BW, Dabrowska K, Switala-Jelen K, Miedzybrodzki R. Bacteriophage translocation. FEMS Immunol Med Microbiol. (2006) 46:313-9. doi: 10.1111/j.1574-695X.2006.00044.x
16. Barr JJ. A bacteriophages journey through the human body. Immunol Rev. (2017) 279:106-22. doi: 10.1111/imr.12565
17. Nguyen S, Baker K, Padman BS, Patwa R, Dunstan RA, Weston TA, et al. Bacteriophage transcytosis provides a mechanism to cross epithelial cell layers. mBio (2017) 8:e01874-17. doi: 10.1128/mBio.01874-17
18. Lehti TA, Pajunen MI, Skog MS, Finne J. Internalization of a polysialic acid-binding Escherichia coli bacteriophage into eukaryotic neuroblastoma cells. Nat Commun. (2017) 8:1915. doi: 10.1038/s41467-017-02057-3
19. Redrejo-Rodriguez M, Munoz-Espin D, Holguera I, Mencia M, Salas M. Functional eukaryotic nuclear localization signals are widespread in terminal proteins of bacteriophages. Proc Natl Acad Sci USA (2012) 109:18482-7. doi: 10.1073/pnas.1216635109
20. Redrejo-Rodriguez M, Munoz-Espin D, Holguera I, Mencia M, Salas M. Nuclear localization signals in phage terminal proteins provide a novel gene delivery tool in mammalian cells. Commun Integr Biol. (2013) 6:e22829. doi: 10.4161/cib.22829
21. Le Y, Gagneten S, Tombaccini D, Bethke B, Sauer B. Nuclear targeting determinants of the phage P1 cre DNA recombinase. Nucleic Acids Res. (1999) 27:4703-9. doi: 10.1093/nar/27.24.4703
22. Ackermann HW. Classification of bacteriophages. In: Calendar R, editor. The Bacteriophages. New York, NY: Oxford University Press (2006), p. 8-16
23. Duerkop BA, Clements CV, Rollins D, Rodrigues JL, Hooper LV. A composite bacteriophage alters colonization by an intestinal commensal bacterium. Proc Natl Acad Sci USA (2012) 109:17621-6. doi: 10.1073/pnas.1206136109
24. Kim MS, Bae JW. Lysogeny is prevalent and widely distributed in the murine gut microbiota. ISME J (2018) 12:1127-41. doi: 10.1038/s41396-018-0061-9
25. Wang X, Kim Y, Ma Q, Hong SH, Pokusaeva K, Sturino JM, et al. Cryptic prophages help bacteria cope with adverse environments. Nat Commun. (2010) 1:147. doi: 10.1038/ncomms1146
26. Brussow H, Canchaya C, Hardt WD. Phages and the evolution of bacterial pathogens: from genomic rearrangements to lysogenic conversion. Microbiol Mol Biol Rev. (2004) 68:560-602. doi: 10.1128/MMBR.68.3.560-602.2004
27. Ghosh D, Roy K, Williamson KE, White DC, Wommack KE, Sublette KL, et al. Prevalence of lysogeny among soil bacteria and presence of 16S rRNA and trzN genes in viral-community DNA. Appl Environ Microbiol. (2008) 74:495-502. doi: 10.1128/AEM.01435-07
28. Mercanti DJ, Guglielmotti DM, Patrignani F, Reinheimer JA, Quiberoni A. Resistance of two temperate Lactobacillus paracaseii bacteriophages to high pressure homogenization, thermal treatments and chemical biocides of industrial application. Food Microbiol. (2012) 29:99-104. doi: 10.1016/j.fm.2011.09.003
29. Paul JH. Prophages in marine bacteria: dangerous molecular time bombs or the key to survival in the seas? ISME J. (2008) 2:579-89. doi: 10.1038/ismej.2008.35
30. Williamson KE, Radosevich M, Smith DW, Wommack KE. Incidence of lysogeny within temperate and extreme soil environments. Environ Microbiol. (2007) 9:2563-74. doi: 10.1111/j.1462-2920.2007.01374.x
31. Lobocka MB, Rose DJ, Plunkett G III, Rusin M, Samojedny A, Lehnherr H, et al. Genome of bacteriophage P1. J Bacteriol. (2004) 186:7032-68. doi: 10.1128/JB.186.21.7032-7068.2004
32. Nanda AM, Thormann K, Frunzke J. Impact of spontaneous prophage induction on the fitness of bacterial populations and host-microbe interactions. J Bacteriol. (2015) 197:410-9. doi: 10.1128/JB.02230-14
33. Ptashne M. A Genetic Switch: Phage Lambda Revisited, 3rd Edn. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press (2004)
34. Wegrzyn G, Wegrzyn A. Genetic switches during bacteriophage lambda development. Prog Nucleic Acid Res Mol Biol. (2005) 79:1-48. doi: 10.1016/S0079-6603(04)79001-7
35. Wegrzyn G, Licznerska K, Wegrzyn A. Phage lambda-new insights into regulatory circuits. Adv Virus Res. (2012) 82:155-78. doi: 10.1016/B978-0-12-394621-8.00016-9
36. Los JM, Los M, Wegrzyn G, Wegrzyn A. Differential efficiency of induction of various lambdoid prophages responsible for production of Shiga toxins in response to different induction agents. Microb Pathog. (2009) 47:289-98. doi: 10.1016/j.micpath.2009.09.006
37. Los JM, Los M, Wegrzyn A, Wegrzyn G. Hydrogen peroxide-mediated induction of the Shiga toxin-converting lambdoid prophage ST2-8624 in Escherichia coli O157:H7. FEMS Immunol Med Microbiol. (2010) 58:322-9. doi: 10.1111/j.1574-695X.2009.00644.x
38. Fang Y, Mercer RG, McMullen LM, Ganzle MG. Induction of shiga toxin-encoding prophage by abiotic environmental stress in food. Appl Environ Microbiol. (2017) 83:e01378-17. doi: 10.1128/AEM.01378-17
39. Los JM, Los M, Wegrzyn A, Wegrzyn G. Altruism of Shiga toxin-producing Escherichia coli: recent hypothesis versus experimental results. Front Cell Infect Microbiol. (2013) 2:166. doi: 10.3389/fcimb.2012.00166
40. Los JM, Los M, Wegrzyn G. Bacteriophages carrying Shiga toxin genes: genomic variations, detection and potential treatment of pathogenic bacteria. Future Microbiol. (2011) 6:909-24. doi: 10.2217/fmb.11.70
41. Licznerska K, Nejman-Falenczyk B, Bloch S, Dydecka A, Topka G, Gasior T, et al. Oxidative stress in Shiga toxin production by enterohemorrhagic Escherichia coli. Oxid Med Cell Longev. (2016) 2016:3578368. doi: 10.1155/2016/3578368
42. Diard M, Bakkeren E, Cornuault JK, Moor K, Hausmann A, Sellin ME, et al. Inflammation boosts bacteriophage transfer between Salmonella spp. Science (2017) 355:1211-5. doi: 10.1126/science.aaf8451
43. Weinbauer MG SC, Suttle CA. Lysogeny and prophage induction in coastal and offshore bacterial communities. Aquat Microb Ecol. (1999) 18:217-25. doi: 10.3354/ame018217
44. Kim S, Ryu K, Biswas D, Ahn J. Survival, prophage induction, and invasive properties of lysogenic Salmonella typhimurium exposed to simulated gastrointestinal conditions. Arch Microbiol. (2014) 196:655-9. doi: 10.1007/s00203-014-1005-z
45. Harris SM, Yue WF, Olsen SA, Hu J, Means WJ, McCormick RJ, et al. Salt at concentrations relevant to meat processing enhances Shiga toxin 2 production in Escherichia coli O157:H7. Int J Food Microbiol. (2012) 159:186-92. doi: 10.1016/j.ijfoodmicro.2012.09.007
46. Colon MP, Chakraborty D, Pevzner Y, Koudelka GB. Mechanisms that determine the differential stability of Stx(+) and Stx(-) lysogens. Toxins (Basel) (2016) 8:96. doi: 10.3390/toxins8040096
47. Imamovic L, Muniesa M. Characterizing RecA-independent induction of Shiga toxin2-encoding phages by EDTA treatment. PLoS ONE (2012) 7:e32393. doi: 10.1371/journal.pone.0032393
48. Lenzi LJ, Lucchesi PM, Medico L, Burgan J, Kruger A. Effect of the food additives sodium citrate and disodium phosphate on Shiga toxin-producing Escherichia coli and production of stx-Phages and Shiga toxin. Front Microbiol. (2016) 7:992. doi: 10.3389/fmicb.2016.00992
49. Motlagh AM, Bhattacharjee AS, Goel R. Microbiological study of bacteriophage induction in the presence of chemical stress factors in enhanced biological phosphorus removal (EBPR). Water Res. (2015) 81:1-14. doi: 10.1016/j.watres.2015.04.023
50. Yamamoto T, Kojio S, Taneike I, Nakagawa S, Iwakura N, Wakisaka-Saito N. 60Co irradiation of Shiga toxin (Stx)-producing Escherichia coli induces Stx phage. FEMS Microbiol Lett. (2003) 222:115-21. doi: 10.1016/S0378-1097(03)00259-3
51. Aertsen A, Faster D, Michiels CW. Induction of Shiga toxin-converting prophage in Escherichia coli by high hydrostatic pressure. Appl Environ Microbiol. (2005) 71:1155-62. doi: 10.1128/AEM.71.3.1155-1162.2005
52. Struk M, Grygorcewicz B, Nawrotek P, Augustyniak A, Konopacki M, Kordas M, et al. Enhancing effect of 50 Hz rotating magnetic field on induction of Shiga toxin-converting lambdoid prophages. Microb Pathog. (2017) 109:4-7. doi: 10.1016/j.micpath.2017.05.018
53. Meessen-Pinard M, Sekulovic O, Fortier LC. Evidence of in vivo prophage induction during Clostridium difficile infection. Appl Environ Microbiol. (2012) 78:7662-70. doi: 10.1128/AEM.02275-12
54. Pierzynowska K, Jasinska W, Cyske Z, Bunikowska M, Droczek R, Wegrzyn G. Effects of some commonly used drinks on induction of Shiga toxin-converting prophage in Escherichia coli. J Consum Prot Food Saf. (2018). doi: 10.1007/s00003-018-1155-z. [Epub ahead of print]
55. Stevens RH, de Moura Martins Lobo Dos Santos C., Zuanazzi D, de Accioly Mattos MB, Ferreira DF, Kachlany SC, et al. Prophage induction in lysogenic Aggregatibacter actinomycetemcomitans cells co-cultured with human gingival fibroblasts, and its effect on leukotoxin release. Microb Pathog. (2013) 54:54-9. doi: 10.1016/j.micpath.2012.09.005
56. Broudy TB, Pancholi V, Fischetti VA. Induction of lysogenic bacteriophage and phage-associated toxin from group a streptococci during coculture with human pharyngeal cells. Infect Immun. (2001) 69:1440-3. doi: 10.1128/IAI.69.3.1440-1443.2001
57. Mezger M, Wozniok I, Blockhaus C, Kurzai O, Hebart H, Einsele H, et al. Impact of mycophenolic acid on the functionality of human polymorphonuclear neutrophils and dendritic cells during interaction with Aspergillus fumigatus. Antimicrob. Agents Chemother (2008) 52:2644-6. doi: 10.1128/AAC.01618-07
58. O'Connell S, Tuite N, Slattery C, Ryan MP, McMorrow T. Cyclosporine A-induced oxidative stress in human renal mesangial cells: a role for ERK 1/2 MAPK signaling. Toxicol Sci. (2012) 126:101-13. doi: 10.1093/toxsci/kfr330
59. Chen MK, Badylak SF. Small bowel tissue engineering using small intestinal submucosa as a scaffold. J Surg Res. (2001) 99:352-8. doi: 10.1006/jsre.2001.6199
60. Houk VS, DeMarini DM. Induction of prophage lambda by chlorinated pesticides. Mutat Res. (1987) 182:193-201. doi: 10.1016/0165-1161(87)90061-6
61. DeMarini DM, Brooks HG, Parkes DG Jr. Induction of prophage lambda by chlorophenols. Environ Mol Mutagen. (1990) 15:1-9. doi: 10.1002/em.2850150102
62. Oikari A, Anas E. Chlorinated phenolics and their conjugates in the bile of trout (Salmo gairdneri) exposed to contaminated waters. Bull Environ Contam Toxicol. (1985) 35:802-9 doi: 10.1007/BF01636591
63. Kan H, Zhao F, Zhang XX, Ren H, Gao S. Correlations of gut microbial community shift with hepatic damage and growth inhibition of Carassius auratus induced by pentachlorophenol exposure. Environ Sci Technol. (2015) 49:11894-902. doi: 10.1021/acs.est.5b02990
64. Seiler JP. Pentachlorophenol. Mutat Res. (1991) 257:27-47. doi: 10.1016/0165-1110(91)90018-Q
65. Ho YL, Ho SK. Screening of carcinogens with the prophage lambda cIts857 induction test. Cancer Res. (1981) 41:532-6
66. Houk VS, DeMarini DM. Use of the microscreen phage-induction assay to assess the genotoxicity of 14 hazardous industrial wastes. Environ Mol Mutagen (1988) 11:13-29. doi: 10.1002/em.2850110104
67. Howe A, Ringus DL, Williams RJ, Choo ZN, Greenwald SM, Owens SM, et al. Divergent responses of viral and bacterial communities in the gut microbiome to dietary disturbances in mice. ISME J. (2016) 10:1217-27. doi: 10.1038/ismej.2015.183
68. Brown CT, Davis-Richardson AG, Giongo A, Gano KA, Crabb DB, Mukherjee N, et al. Gut microbiome metagenomics analysis suggests a functional model for the development of autoimmunity for type 1 diabetes. PLoS ONE (2011) 6:e25792. doi: 10.1371/journal.pone.0025792
69. Ghosh D, Roy K, Williamson KE, Srinivasiah S, Wommack KE, Radosevich M. Acyl-homoserine lactones can induce virus production in lysogenic bacteria: an alternative paradigm for prophage induction. Appl Environ Microbiol. (2009) 75:7142-52. doi: 10.1128/AEM.00950-09
70. Chen X, Schauder S, Potier N, Van Dorsselaer A, Pelczer I, Bassler BL, et al. Structural identification of a bacterial quorum-sensing signal containing boron. Nature (2002) 415:545-9. doi: 10.1038/415545a
71. Miller ST, Xavier KB, Campagna SR, Taga ME, Semmelhack MF, Bassler BL, et al. Salmonella typhimurium recognizes a chemically distinct form of the bacterial quorum-sensing signal AI-2. Mol Cell. (2004) 15:677-87. doi: 10.1016/j.molcel.2004.07.020
72. Semmelhack MF, Campagna SR, Hwa C, Federle MJ, Bassler BL. Boron binding with the quorum sensing signal AI-2 and analogues. Org Lett. (2004) 6:2635-7. doi: 10.1021/ol048976u
73. Rickard AH, Palmer RJ, Jr, Blehert DS, Campagna SR, Semmelhack MF, Egland PG, et al. Autoinducer 2: a concentration-dependent signal for mutualistic bacterial biofilm growth. Mol Microbiol. (2006) 60:1446-56. doi: 10.1111/j.1365-2958.2006.05202.x
74. Zhu J, Kaufmann GF. Quo vadis quorum quenching? Curr Opin Pharmacol. (2013) 13:688-98. doi: 10.1016/j.coph.2013.07.003
75. Schauder S, Shokat K, Surette MG, Bassler BL. The LuxS family of bacterial autoinducers: biosynthesis of a novel quorum-sensing signal molecule. Mol Microbiol. (2001) 41:463-76. doi: 10.1046/j.1365-2958.2001.02532.x
76. Rossmann FS, Racek T, Wobser D, Puchalka J, Rabener EM, Reiger M, et al. Phage-mediated dispersal of biofilm and distribution of bacterial virulence genes is induced by quorum sensing. PLoS Pathog. (2015) 11:e1004653. doi: 10.1371/journal.ppat.1004653
77. Matos RC, Lapaque N, Rigottier-Gois L, Debarbieux L, Meylheuc T, Gonzalez-Zorn B, et al. Enterococcus faecalis prophage dynamics and contributions to pathogenic traits. PLoS Genet. (2013) 9:e1003539. doi: 10.1371/journal.pgen.1003539
78. Yasmin A, Kenny JG, Shankar J, Darby AC, Hall N, Edwards C, et al. Comparative genomics and transduction potential of Enterococcus faecalis temperate bacteriophages. J Bacteriol. (2010) 192:1122-30. doi: 10.1128/JB.01293-09
79. Sender R, Fuchs S, Milo R. Revised estimates for the number of human and bacteria cells in the body. PLoS Biol. (2016) 14:e1002533. doi: 10.1371/journal.pbio.1002533
80. Martinez-Castillo A, Quiros P, Navarro F, Miro E, Muniesa M. Shiga toxin 2-encoding bacteriophages in human fecal samples from healthy individuals. Appl Environ Microbiol. (2013) 79:4862-8. doi: 10.1128/AEM.01158-13
81. Tyler JS, Beeri K, Reynolds JL, Alteri CJ, Skinner KG, Friedman JH, et al. Prophage induction is enhanced and required for renal disease and lethality in an EHEC mouse model. PLoS Pathog. (2013) 9:e1003236. doi: 10.1371/journal.ppat.1003236
82. Carding SR, Davis N, Hoyles L. Review article: the human intestinal virome in health and disease. Aliment Pharmacol Ther. (2017) 46:800-15. doi: 10.1111/apt.14280
83. Górski A, Weber-Dabrowska B. The potential role of endogenous bacteriophages in controlling invading pathogens. Cell Mol Life Sci. (2005) 62:511-9. doi: 10.1007/s00018-004-4403-6
84. Miedzybrodzki R, Klak M, Jonczyk-Matysiak E, Bubak B, Wójcik A, Kaszowska M, et al. Means to facilitate the overcoming of gastric juice barrier by a therapeutic staphylococcal bacteriophage A5/80. Front Microbiol. (2017) 8:467. doi: 10.3389/fmicb.2017.00467
85. Hattori Y, Hattori K, Suzuki T, Matsuda N. Recent advances in the pathophysiology and molecular basis of sepsis-associated organ dysfunction: Novel therapeutic implications and challenges. Pharmacol Ther. (2017) 177:56-66. doi: 10.1016/j.pharmthera.2017.02.040
86. Minasyan H. Sepsis and septic shock: Pathogenesis and treatment perspectives. J Crit Care (2017) 40:229-42. doi: 10.1016/j.jcrc.2017.04.015
87. Górski A, Miedzybrodzki R, Borysowski J, Dabrowska K, Wierzbicki P, Ohams M, et al. Phage as a modulator of immune responses: practical implications for phage therapy. Adv Virus Res. (2012) 83:41-71. doi: 10.1016/B978-0-12-394438-2.00002-5
88. Borysowski J, Górski A. Is phage therapy acceptable in the immunocompromised host? Int J Infect Dis. (2008) 12:466-71. doi: 10.1016/j.ijid.2008.01.006
89. Danikas DD, Karakantza M, Theodorou GL, Sakellaropoulos GC, Gogos CA. Prognostic value of phagocytic activity of neutrophils and monocytes in sepsis. Correlation to CD64 and CD14 antigen expression. Clin Exp Immunol. (2008) 154:87-97. doi: 10.1111/j.1365-2249.2008.03737.x
90. Górski A, Jonczyk-Matysiak E, Lusiak-Szelachowska M, Miedzybrodzki R, Weber-Dabrowska B, Borysowski J. Bacteriophages targeting intestinal epithelial cells: a potential novel form of immunotherapy. Cell Mole Life Sci. (2017). 75:589-95. doi: 10.1007/s00018-017-2715-6
91. Kakinuma Y, Kimura T, Watanabe Y. Possible involvement of liver resident macrophages (Kupffer cells) in the pathogenesis of both intrahepatic and extrahepatic inflammation. Can J Gastroenterol Hepatol. (2017) 2017:2896809. doi: 10.1155/2017/2896809
92. Karimi MH, Geramizadeh B, Malek-Hosseini SA. Tolerance induction in liver. Int J Organ Transplant Med. (2015) 6:45-54
93. Zhang M, Xu S, Han Y, Cao X. Apoptotic cells attenuate fulminant hepatitis by priming Kupffer cells to produce interleukin-10 through membrane-bound TGF-β. Hepatology (2011) 53:306-16. doi: 10.1002/hep.24029
94. Inchley CJ. The actvity of mouse Kupffer cells following intravenous injection of T4 bacteriophage. Clin Exp Immunol. (1969) 5:173-87
95. Górski A, Jonczyk-Matysiak E, lusiak-Szelachowska M, Weber-Dabrowska B, Miedzybrodzki R, Borysowski J. Therapeutic potential of phages in autoimmune liver diseases. Clin Exp Immunol. (2018). 192:1-6. doi: 10.1111/cei.13092
96. Akdis CA, Blesken T, Akdis M, Wuthrich B, Blaser K. Role of interleukin 10 in specific immunotherapy. J Clin Invest. (1998) 102:98-106. doi: 10.1172/JCI2250
97. Keane-Myers AM, Miyazaki D, Liu G, Dekaris I, Ono S, Dana MR. Prevention of allergic eye disease by treatment with IL-1 receptor antagonist. Invest Ophthalmol Vis Sci. (1999) 40:3041-6
98. Zhvania P, Hoyle NS, Nadareishvili L, Nizharadze D, Kutateladze M. Phage therapy in a 16-year-old boy with netherton syndrome. Front Med. (Lausanne) (2017) 4:94. doi: 10.3389/fmed.2017.00094
99. Miedzybrodzki R, Borysowski J, Weber-Dabrowska B, Fortuna W, Letkiewicz S, Szufnarowski K, et al. Clinical aspects of phage therapy. Adv Virus Res. (2012) 83:73-121. doi: 10.1016/B978-0-12-394438-2.00003-7
100. Mills AE. Staphylococcus bacteriophage lysate aerosol therapy of sinusitis. Laryngoscope (1956) 66:846-58. doi: 10.1288/00005537-195607000-00004
101. Górski A, Jonczyk-Matysiak E, Lusiak-Szelachowska M, Miedzybrodzki R, Weber-Dabrowska B, Borysowski J. Phage therapy in allergic disorders? Exp Biol Med. (Maywood) (2018) 1:534-7. doi: 10.1177/1535370218755658